encyclopedia of medical concepts
ψ 

Auranofin

More information in Books or onNLM PubMed
Definition: An oral chrysotherapeutic agent for the treatment of rheumatoid arthritis. Its exact mechanism of action is unknown, but it is believed to act via immunological mechanisms and alteration of lysosomal enzyme activity. Its efficacy is slightly less than that of injected gold salts, but it is better tolerated, and side effects which occur are potentially less serious.     
Pharmacological Action Antirheumatic Agents 		Other names SK&F39162; SK&F 39162; Auranofin Yamanouchi Brand; Auranofin Rubio Brand; Auranofin Robapharm Brand; Auranofin Recordati Brand; Yamanouchi Brand of Auranofin; SmithKline Beecham Brand of Auranofin; SK&F-39162; Rubio Brand of Auranofin; Robapharm Brand of Auranofin; Ridauran; Recordati Brand of Auranofin; SK&F D 39162; Crisinor; RidauraDrugs* : RIDAURA

To share this definition, click "text" (Facebook, Twitter) or "link" (blog, mail) then paste text link
Ads by Google

Sources: NLM Medical Subject Headings, NIH UMLS, Drugs@FDA, FDA AERS original data copyright United States Government. No endorsement implied. Last modified 6/6/2012
Warning: the drugs or drug combinations referred to here may be similar or related, but are not be the same ones and may not have the same pharmacological action as other substances described on the same page or in the same row. Please refer to product monograph or to your doctor
This website is accredited by Health On the Net Foundation. Click to verify. We comply with the HONcode standard for trustworthy health information: verify here.
About Reference.MD Privacy